Abstract
Ototoxic drugs, intense sound or age-related hearing loss recruit most of the apoptotic pathways, but also several additional enzymatic pathways which eventually result in cell death. Here, we discuss therapeutic strategies based on the inhibition of regulators or executors of apoptotic cell death pathways and on the use of antioxidants.
Keywords: Apoptosis, necrosis, cell death pathway, cochlea, therapeutic strategies, ototoxic drugs, intense sound, age-related hearing loss
Mini-Reviews in Medicinal Chemistry
Title: From Cochlear Cell Death Pathways To New Pharmacological Therapies
Volume: 8 Issue: 10
Author(s): Jing Wang and Jean-Luc Puel
Affiliation:
Keywords: Apoptosis, necrosis, cell death pathway, cochlea, therapeutic strategies, ototoxic drugs, intense sound, age-related hearing loss
Abstract: Ototoxic drugs, intense sound or age-related hearing loss recruit most of the apoptotic pathways, but also several additional enzymatic pathways which eventually result in cell death. Here, we discuss therapeutic strategies based on the inhibition of regulators or executors of apoptotic cell death pathways and on the use of antioxidants.
Export Options
About this article
Cite this article as:
Wang Jing and Puel Jean-Luc, From Cochlear Cell Death Pathways To New Pharmacological Therapies, Mini-Reviews in Medicinal Chemistry 2008; 8(10) . https://dx.doi.org/10.2174/138955708785740599
DOI https://dx.doi.org/10.2174/138955708785740599 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Proteomic Classification of Breast Cancer
Current Drug Targets Preclinical Evidence on the Anticancer Properties of Food Peptides
Protein & Peptide Letters Neurokinin-1 Receptor Antagonist Can Prevent the Delayed Phase in Patients: A Single Center Retrospect Study
Anti-Cancer Agents in Medicinal Chemistry Structural Analysis for Colchicine Binding Site-Targeted ATCAA Derivatives as Melanoma Antagonists
Medicinal Chemistry Functions of MAPR (Membrane-Associated Progesterone Receptor) Family Members As Heme/Steroid-Binding Proteins
Current Protein & Peptide Science In Vitro, In Vivo and In Silico Analysis of the Anticancer and Estrogen-like Activity of Guava Leaf Extracts
Current Medicinal Chemistry Prothymosin Alpha: An Alarmin and More...
Current Medicinal Chemistry Tumor-Targeted Inhibition by a Novel Strategy - Mimoretrovirus Expressing siRNA Targeting the Pokemon Gene
Current Cancer Drug Targets Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Studies of NVP-BEZ235 in Melanoma
Current Cancer Drug Targets Current Development in Encapsulated Cell Therapy for Degenerative Retinopathies
Current Tissue Engineering (Discontinued) Drugs and their Interactions
Current Drug Discovery Technologies Diagnostic and Therapeutic Applications of Radiolabeled Somatostatin Analogs: Current Status in an Oncology Center
Current Pharmaceutical Design Manipulation of Dendritic Cells for Tumor Immunity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling
Current Cancer Drug Targets Angiogenesis as a therapeutic target in breast cancer
Mini-Reviews in Medicinal Chemistry Box-Behnken Design Optimized TPGS Coated Bovine Serum Albumin Nanoparticles Loaded with Anastrozole
Current Drug Delivery Synthesis and Some Reactions of 1-aryl-4-acetyl-5-methyl-1,2,3-triazole Derivatives with Anticonvulsant Activity
Mini-Reviews in Medicinal Chemistry Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Association of Common Variants in the IL-33/ST2 Axis with Ischemic Stroke
Current Neurovascular Research